Formula: | C22H32N4O4S |
Molecular Weight: | 448.59 |
Rotatable Bond Donors: | 2 |
clogP: | 2.18 |
Topological Polar Surface Area: | 90.03 |
Lipinski's RO5: | MW: 448.59 HBA: 8 HBD: 1 RB: 2 LogP: 2.18 |
Rule of Three: | MW: 448.59 HBA: 8 HBD: 1 RB: 2 LogP: 2.18 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS31844 | 0.7 | EOS31844 RDKit 3D 29 32 0 0 0 0 0 0 0 0999 V2000 3.2287 -0.7163 1.5542 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6874 -0.8842 0.1635 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8888 -1.4251 -0.0647 N 0 0 0 0 0 0 0 0 0 0 0 0 5.0662 -1.3682 -1.4356 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9727 -0.8039 -2.0068 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0123 -0.6483 -3.4676 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0390 -0.5064 -1.0397 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7538 0.1149 -1.2790 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6104 0.9808 -2.1408 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6881 -0.2997 -0.4860 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6323 -1.6486 0.0270 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2303 -1.7163 1.2646 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5596 -1.0080 1.1269 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.6892 -1.9121 0.8415 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.6876 -3.1363 1.6503 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1131 -2.1329 -0.7702 S 0 0 0 0 0 0 0 0 0 0 0 0 -1.9230 -2.5592 -1.4730 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.3401 -2.8931 -0.8158 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.4650 -0.4510 -1.2430 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9836 0.5585 -0.2151 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5794 0.2934 0.3256 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.2130 1.4275 1.2779 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9726 1.2025 2.4663 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1701 2.7067 0.7805 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8074 3.8030 1.6474 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5833 4.9857 0.7240 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3309 4.6384 -0.5511 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3475 3.1228 -0.5934 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5841 0.2755 -0.8222 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 1 0 5 6 1 0 5 7 2 0 7 8 1 0 8 9 2 0 8 10 1 0 10 11 1 0 11 12 1 0 13 12 1 1 13 14 1 0 14 15 1 0 14 16 1 0 16 17 2 0 16 18 2 0 16 19 1 0 19 20 1 0 20 21 1 0 21 22 1 1 22 23 2 0 22 24 1 0 24 25 1 0 25 26 1 0 26 27 1 0 27 28 1 0 21 29 1 0 7 2 1 0 29 10 1 0 21 13 1 0 28 24 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |